In chronic tension headache patients, paroxetine (SSRI) increased CSF met-enkephalin while sulpiride (dopamine blocker) decreased it after 8 weeks of treatment.
Opposite effectsTwo headache drugs moved met-enkephalin in opposite directions after 8 weeks — revealing fundamentally different mechanisms
What the researchers found
Sulpiride decreased CSF met-enkephalin while paroxetine increased it in chronic tension headache patients after 8 weeks of treatment.
Why it matters
Chronic tension headaches are common and hard to treat. Understanding how drugs change neuropeptide levels in the brain helps explain why some treatments work and guides development of better options.
How the study worked
Patients with chronic tension-type headache underwent lumbar puncture before and after 8 weeks of treatment with either sulpiride or paroxetine. CSF levels of beta-endorphin, met-enkephalin, dynorphin, CCK, CGRP, and somatostatin were measured.
What this study cannot tell us
Small clinical study. Lumbar CSF may not perfectly reflect brain peptide levels at the sites that cause headaches. No placebo control group.
How to read the evidence
Moderate — randomized trial measuring CSF neuropeptides before and after treatment. No placebo control limits interpretation.
When this study was published
Published in 1994 (32 years ago). SSRIs remain first-line for chronic headache; the neuropeptide mechanism adds understanding.
The bigger picture
Chronic headaches affect millions. Understanding that treatments change brain opioid levels differently could help match patients to the right medication and explain why some respond better to one drug class than another.
Questions still open
- Does the met-enkephalin change correlate with headache improvement?
- Could measuring CSF peptides help predict which headache treatment will work?
Common questions
How do antidepressants help headaches?
Why does the dopamine blocker decrease opioid levels?
Read the original research
Effect of sulpiride or paroxetine on cerebrospinal fluid neuropeptide concentrations in patients with chronic tension-type headache.
Neuropeptides, 27(2), 129-36
Citation
Bach, F W; Langemark, M; Ekman, R; Rehfeld, J F; Schifter, S; Olesen, J. (1994). Effect of sulpiride or paroxetine on cerebrospinal fluid neuropeptide concentrations in patients with chronic tension-type headache.. Neuropeptides, 27(2), 129-36.